Haemonetics Corp (HAE) Q3 2025 Earnings Call Highlights: Strong Hospital Growth Amid Plasma ... [Yahoo! Finance]
Haemonetics Corporation (HAE)
Last haemonetics corporation earnings: 2/4 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=72118&p=irol-irhome
Company Research
Source: Yahoo! Finance
4 min read In This Article HAE Revenue: $349 million, 4% growth on a reported basis, flat organically. Adjusted Earnings Per Share (EPS): $1.19, up 14% year-over-year. Hospital Revenue Growth: 24% reported, 12% organic in the third quarter. Hemostasis Management Revenue Growth: 26% in the US. Interventional Technologies Growth: 47% reported, 16% organic in the third quarter. Plasma Revenue Decline: 9% in the third quarter. Adjusted Gross Margin: 57.7%, an increase of 240 basis points year-over-year. Adjusted Operating Expenses: $111.5 million, 32% of revenue, down 150 basis points year-over-year. Adjusted Operating Income: $89.4 million, 25.7% of revenue, a 390-basis point increase year-over-year. Adjusted Net Income: $60.3 million, up 13% year-over-year. Free Cash Flow: $49.7 million year-to-date. Cash on Hand: $320.8 million at the end of the quarter. Net Leverage Ratio: Approximately 2.42 times EBITDA. Warning! GuruFocus has detected 2 Warning Sign
Show less
Read more
Impact Snapshot
Event Time:
HAE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HAE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HAE alerts
High impacting Haemonetics Corporation news events
Weekly update
A roundup of the hottest topics
HAE
News
- Haemonetics (NYSE:HAE) had its price target raised by analysts at Mizuho from $75.00 to $90.00. They now have an "outperform" rating on the stock.MarketBeat
- Riverwater Partners Small Cap Strategy Sold Its Stake in Haemonetics Corporation (HAE) in Q3 [Yahoo! Finance]Yahoo! Finance
- Haemonetics (NYSE:HAE) was upgraded by analysts at CJS Securities to a "strong-buy" rating.MarketBeat
- Haemonetics (NYSE:HAE) was given a new $99.00 price target on by analysts at Robert W. Baird.MarketBeat
- Haemonetics (NYSE:HAE) was downgraded by analysts at Needham & Company LLC from a "buy" rating to a "hold" rating.MarketBeat
HAE
Earnings
- 11/7/25 - Beat
HAE
Sec Filings
- 11/12/25 - Form 4
- 11/6/25 - Form 10-Q
- 11/6/25 - Form 8-K
- HAE's page on the SEC website